Veru, Inc. (VERU)
2.39
+0.07
(+3.02%)
USD |
NASDAQ |
Sep 17, 10:26
Veru Total Return Level : 2.712 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 2.712 |
| September 15, 2026 | 2.736 |
| September 14, 2026 | 2.736 |
| September 11, 2026 | 2.852 |
| September 10, 2026 | 2.922 |
| September 09, 2026 | 2.899 |
| September 08, 2026 | 3.016 |
| September 04, 2026 | 3.086 |
| September 03, 2026 | 3.098 |
| September 02, 2026 | 3.215 |
| September 01, 2026 | 3.145 |
| August 31, 2026 | 3.273 |
| August 28, 2026 | 3.069 |
| August 27, 2026 | 3.203 |
| August 26, 2026 | 3.273 |
| August 25, 2026 | 3.168 |
| August 24, 2026 | 3.028 |
| August 21, 2026 | 3.086 |
| August 20, 2026 | 3.016 |
| August 19, 2026 | 3.086 |
| August 18, 2026 | 3.028 |
| August 17, 2026 | 3.074 |
| August 14, 2026 | 3.191 |
| August 13, 2026 | 3.156 |
| August 12, 2026 | 3.203 |
| Date | Value |
|---|---|
| August 11, 2026 | 3.262 |
| August 10, 2026 | 3.238 |
| August 07, 2026 | 2.724 |
| August 06, 2026 | 2.700 |
| August 05, 2026 | 2.724 |
| August 04, 2026 | 2.770 |
| August 03, 2026 | 2.642 |
| July 31, 2026 | 2.619 |
| July 30, 2026 | 2.595 |
| July 29, 2026 | 2.584 |
| July 28, 2026 | 2.607 |
| July 27, 2026 | 2.665 |
| July 24, 2026 | 2.630 |
| July 23, 2026 | 2.700 |
| July 22, 2026 | 2.642 |
| July 21, 2026 | 2.736 |
| July 20, 2026 | 2.689 |
| July 17, 2026 | 2.782 |
| July 16, 2026 | 2.747 |
| July 15, 2026 | 2.829 |
| July 14, 2026 | 2.700 |
| July 13, 2026 | 2.993 |
| July 10, 2026 | 3.250 |
| July 09, 2026 | 3.285 |
| July 08, 2026 | 3.110 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ANI Pharmaceuticals, Inc. | 73.59 |
| Corcept Therapeutics, Inc. | 111.81 |
| Johnson & Johnson | 637.79 |
| Eli Lilly & Co. | 3006.36 |
| Lexicon Pharmaceuticals, Inc. | 2.02 |